Skip to content

EBITDA at other companies

Repligen logo
RepligenRGEN
$35.7M+41.2%
ADMA Biologics logo
ADMA BiologicsADMA
$60.07M+63.3%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

$2.2Mebit+
$11.4MDepreciation Depletion & Amortization
=$9.21M

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s EBITDA?
Maravai LifeSciences Holdings, Inc. (MRVI) reported EBITDA of $9.21M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s EBITDA changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s EBITDA increased by 125.3% year-over-year, from -$36.44M to $9.21M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s EBITDA has grown at a -27.1% compound annual growth rate (CAGR), from $579.4M to -$163.76M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.